ALDH1A3 and neoplasm: Analysis of the 90 patients meeting these criteria showed poor prognosis in the group of patients with high ALDH1A3 and ALDH3A1 expression (P = 0.031 and P = 0.005, log-rank test; Fig. 1c right, Table 1), suggesting that ALDH1A3 and ALDH3A1 may affect not only early-stage patient prognosis but also the tumor response to chemotherapy.